MRIgFUS is non-invasive, results in minimal tissue damage and has potential for repeated cell delivery. polysialic acid) suggesting they survived after transplantation with MRIgFUS. Furthermore, delivered stem cells expressed doublecortinin vivoindicating the stem cells were capable of differentiating into neurons. Together, we demonstrate that transient opening of the BBB with MRIgFUS is sufficient for transplantation of stem cells from the blood to targeted brain structures. These results suggest that MRIgFUS may be an effective alternative to invasive intracranial surgery for stem cell transplantation. == Introduction == Significant progress in the field of stem cell therapy for neurodegenerative diseases, brain injuries, AS 2444697 and ischemic stroke highlights its great potential and remaining challenges[1],[2]. One of the important findings is that neural stem cells transplanted into the brain can survive long term and exert positive effects on the symptoms of disease[3]. For example, in a series of open-label clinical trials where human fetal stem cells were grafted into patients with Parkinson’s disease, significant improvements in motor function and timing were observed[3][5]. In an animal model of Parkinson’s disease, grafted mesenchymal cells have a neuroprotective effect Mouse monoclonal to c-Kit on remaining dopaminergic neurons[6]. Also, grafted neural stem cells integrated into the brain and were found to restore motor function[7]. Recently, neural stem cell transplantation was shown to improve cognition in mouse models of Alzheimer’s disease[8]. Furthermore, stem cells have been shown to dramatically improve functional recovery in models of ischemic stroke[1]. One major limitation for the translation of these potential stem cell therapies to clinical practice is the risk associated with invasive cell transplantation methods and the limitation of unwanted repeated surgeries. Intracerebral transplantation of stem cells is the most commonly used method of stem cell delivery to the brain. There are many risks associated with this invasive method, such as risks of surgery, direct tissue trauma causing inflammation and edema[9]as well as graft rejection from immunological response[10]. Other methods to circumvent the risks of surgical transplantation such as intranasal delivery have been proposed but they are untargeted, requiring the cells to migrate to the appropriate brain regions[11]. Intraarterial infusion of hyperosmotic solutions like mannitol, effectively disrupt the BBB and are a potential method for improving stem cell delivery[12]. However, these agents may have serious side effects as they allow potentially cytotoxic compounds present in the blood direct access to the entire CNS for long periods of time. To circumvent the problems associated with invasive surgeries and to provide localized delivery of stem cells to specific brain regions, we investigated the potential of MRIgFUS to deliver stem cells injected into the bloodstream to the AS 2444697 brain. Advances in FUS technology have been used to transiently increase the permeability of the BBB, allowing agents to cross from the blood stream AS 2444697 AS 2444697 to the brain[13]. FUS applies concentrated acoustic energy on a focal spot measuring a few millimeters in diameter[13]. A microbubble contrast agent is administered systemically and when FUS is applied transcranially to a specific location, the circulating microbubbles begin to oscillate. This leads to changes in the blood vessel wall and a transient increase in the permeability of the BBB[14]. Previous work has shown that transient changes in BBB permeability by FUS allows entry of chemotherapeutics and therapeutic antibodies to targeted areas of the brain[15],[16]. In this study, we demonstrate that FUS-induced BBB disruption allows neural stem cells to move from the blood stream into the brain tissue. Furthermore, using MRI guidance, we were able to target specific, clinically relevant structures for BBB disruption as well as confirm the entry of iron-loaded stem cells. AS 2444697 Finally, our results show that the neural stem cells survived well up to 24 hours after FUS indicating that this technique is a powerful option for non-invasive, targeted delivery of neural stem cells to the brain. == Results == == MRIgFUS increases BBB permeability and permits.
Categories:trpp